1. Home
  2. FUN vs AGIO Comparison

FUN vs AGIO Comparison

Compare FUN & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

HOLD

Current Price

$19.98

Market Cap

1.7B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$32.67

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUN
AGIO
Founded
1983
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
FUN
AGIO
Price
$19.98
$32.67
Analyst Decision
Buy
Buy
Analyst Count
12
8
Target Price
$23.92
$39.88
AVG Volume (30 Days)
1.6M
952.6K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,100,289,000.00
$43,011,000.00
Revenue This Year
$4.76
$74.95
Revenue Next Year
$3.73
$165.77
P/E Ratio
N/A
N/A
Revenue Growth
14.45
N/A
52 Week Low
$12.51
$22.24
52 Week High
$38.27
$46.00

Technical Indicators

Market Signals
Indicator
FUN
AGIO
Relative Strength Index (RSI) 65.79 59.32
Support Level $14.85 $26.64
Resistance Level $27.37 $36.35
Average True Range (ATR) 0.96 1.46
MACD 0.29 0.24
Stochastic Oscillator 92.44 59.22

Price Performance

Historical Comparison
FUN
AGIO

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: